reglab/housing_qa huggingface dataset:
WA Rev Code § 69.70.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.020 - Donations of prescription drugs and supplies—Distribution.

RCW 69.70.020 Donations of prescription drugs and supplies—Distribution.(1) Any practitioner, pharmacist, medical facility, drug manufacturer, or drug wholesaler may donate prescription drugs and supplies to a pharmacy for redistribution without compensation or the expectation of compensation to individuals who meet the prioritization criteria established in RCW 69.70.040. Donations of prescription drugs and supplies may be made on the premises of a pharmacy that elects to participate in the provisions of this chapter. A pharmacy that receives prescription drugs or supplies may distribute the prescription drugs or supplies to another pharmacy, pharmacist, or prescribing practitioner for use pursuant to the program.(2) The person to whom a prescription drug was prescribed, or the person's representative, may donate prescription drugs under subsection (1) of this section if, as determined by the professional judgment of a pharmacist, prescription drugs:(a) Equipped with a time temperature indicator at the point of manufacture were stored under required temperature conditions using the prescription drugs' time temperature indicator information and the person, or the person's representative, has completed and signed a donor form, adopted by the department, to release the prescription drug for distribution under this chapter and certifying that the donated prescription drug has never been opened, used, adulterated, or misbranded; or(b) Not equipped with a time temperature indicator at the point of manufacture, were properly stored and the person, or the person's representative, has completed and signed a donor form, adopted by the department, to release the prescription drugs for distribution under this chapter and certified that the donated prescription drugs have never been opened, used, adulterated, or misbranded. The donor form must require that the person, or the person's representative, attest that the donated prescription drugs have been stored in a manner and location that adheres to the conditions established by the manufacturer.[ 2017 c 205 § 1; 2016 c 43 § 2; 2013 c 260 § 2.]NOTES:Effective date—2017 c 205: "This act is necessary for the immediate preservation of the public peace, health, or safety, or support of the state government and its existing public institutions, and takes effect immediately [May 5, 2017]." [ 2017 c 205 § 2.]Effective date—Short title—2016 c 43: See notes following RCW 69.70.010.
WA Rev Code § 69.70.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.030 - Immunity—Eligibility.

RCW 69.70.030 Immunity—Eligibility.To be eligible for the immunity in RCW 69.70.070, a person distributing donated prescription drugs under this chapter must:(1) Meet all requirements in RCW 69.70.050 and any applicable rules related to the return or exchange of prescription drugs or supplies adopted by the *board of pharmacy;(2) Maintain records of any prescription drugs and supplies donated to the pharmacy and subsequently dispensed by the pharmacy; and(3) Identify itself to the public as participating in this chapter.[ 2013 c 260 § 3.]NOTES:*Reviser's note: Chapter 19, Laws of 2013 changed "state board of pharmacy" to "pharmacy quality assurance commission."
WA Rev Code § 69.70.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.040 - Dispensing of donated prescription drugs and supplies—Priority given to individuals who are uninsured.

RCW 69.70.040 Dispensing of donated prescription drugs and supplies—Priority given to individuals who are uninsured.Pharmacies, pharmacists, and prescribing practitioners that elect to dispense donated prescription drugs and supplies under this chapter shall give priority to individuals who are uninsured. If an uninsured individual has not been identified as in need of available prescription drugs and supplies, those prescription drugs and supplies may be dispensed to other individuals expressing need.[ 2016 c 43 § 3; 2013 c 260 § 4.]NOTES:Effective date—Short title—2016 c 43: See notes following RCW 69.70.010.
WA Rev Code § 69.70.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.050 - Acceptance and dispensing of prescription drugs or supplies—Requirements—Recalls—Reselling—Reimbursement, related dispensing fees—Manufacturer registration.

RCW 69.70.050 Acceptance and dispensing of prescription drugs or supplies—Requirements—Recalls—Reselling—Reimbursement, related dispensing fees—Manufacturer registration.(1) Prescription drugs or supplies may be accepted and dispensed under this chapter if all of the following conditions are met:(a) The prescription drug is in:(i) Its original sealed and tamper evident packaging; or(ii) An opened package if it contains single unit doses that remain intact;(b) The prescription drug bears an expiration date that is more than six months after the date the prescription drug was donated;(c) The prescription drug or supplies are inspected before the prescription drug or supplies are dispensed by a pharmacist employed by or under contract with the pharmacy, and the pharmacist determines that the prescription drug or supplies are not adulterated or misbranded;(d) The prescription drug or supplies are prescribed by a practitioner for use by an eligible individual and are dispensed by a pharmacist; and(e) Any other safety precautions established by the department have been satisfied.(2)(a) If a person who donates prescription drugs or supplies to a pharmacy under this chapter receives a notice that the donated prescription drugs or supplies have been recalled, the person shall notify the pharmacy of the recall.(b) If a pharmacy that receives and distributes donated prescription drugs to another pharmacy, pharmacist, or prescribing practitioner under this chapter receives notice that the donated prescription drugs or supplies have been recalled, the pharmacy shall notify the other pharmacy, pharmacist, or prescribing practitioner of the recall.(c) If a person collecting or distributing donated prescription drugs or supplies under this chapter receives a recall notice from the drug manufacturer or the federal food and drug administration for donated prescription drugs or supplies, the person shall immediately remove all recalled medications from stock and comply with the instructions in the recall notice.(3) Prescription drugs and supplies donated under this chapter may not be resold.(4) Prescription drugs and supplies dispensed under this chapter shall not be eligible for reimbursement of the prescription drug or any related dispensing fees by any public or private health care payer.(5) A prescription drug that can only be dispensed to a patient registered with the manufacturer of that drug, in accordance with the requirements established by the federal food and drug administration, may not be distributed under the program, unless the patient receiving the prescription drug is registered with the manufacturer at the time the drug is dispensed and the amount dispensed does not exceed the duration of the registration period.[ 2016 c 43 § 4; 2013 c 260 § 5.]NOTES:Effective date—Short title—2016 c 43: See notes following RCW 69.70.010.
WA Rev Code § 69.70.060 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.060 - Form—Department to develop.

RCW 69.70.060 Form—Department to develop.The department shall develop a form for persons to use when releasing prescription drugs for distribution and certifying the condition of the drugs, as provided in RCW 69.70.020(2).[ 2016 c 43 § 5; 2013 c 260 § 6.]NOTES:Effective date—Short title—2016 c 43: See notes following RCW 69.70.010.
WA Rev Code § 69.70.070 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.070 - Liability.

RCW 69.70.070 Liability.(1) A drug manufacturer acting in good faith may not, in the absence of a finding of gross negligence, be subject to criminal prosecution or liability in tort or other civil action, for injury, death, or loss to person or property for matters relating to the donation, acceptance, or dispensing of any drug manufactured by the drug manufacturer that is donated by any person under the program including, but not limited to:(a) Liability for failure to transfer or communicate product or consumer information or the expiration date of the donated prescription drug; and(b) Liability related to prescription drugs that can only be dispensed to a patient registered with the manufacturer of that drug, in accordance with the requirements established by the federal food and drug administration.(2) Any person or entity, other than a drug manufacturer subject to subsection (1) of this section, acting in good faith in donating, accepting, or distributing prescription drugs under this chapter is immune from criminal prosecution, professional discipline, or civil liability of any kind for any injury, death, or loss to any person or property relating to such activities other than acts or omissions constituting gross negligence or willful or wanton misconduct.(3) The immunity provided under subsection (1) of this section does not absolve a drug manufacturer of a criminal or civil liability that would have existed but for the donation, nor does such donation increase the liability of the drug manufacturer in such an action.[ 2016 c 43 § 6; 2013 c 260 § 7.]NOTES:Effective date—Short title—2016 c 43: See notes following RCW 69.70.010.
WA Rev Code § 69.70.080 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.080 - Availability of access.

RCW 69.70.080 Availability of access.Access to prescription drugs and supplies under this chapter is subject to availability. Nothing in this chapter establishes an entitlement to receive prescription drugs and supplies through the program.[ 2013 c 260 § 8.]
WA Rev Code § 69.70.090 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.090 - Samples.

RCW 69.70.090 Samples.Nothing in this chapter restricts the use of samples by a practitioner during the course of the practitioner's duties at a medical facility or pharmacy.[ 2013 c 260 § 9.]
WA Rev Code § 69.70.100 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.100 - Resale of prescription drugs not authorized.

RCW 69.70.100 Resale of prescription drugs not authorized.Nothing in this chapter authorizes the resale of prescription drugs by any person.[ 2013 c 260 § 10.]
WA Rev Code § 69.70.110 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.110 - Prescription drug donation—Rules.

RCW 69.70.110 Prescription drug donation—Rules.The pharmacy quality assurance commission may adopt rules to allow the safe donation of prescription drugs under this chapter including, but not limited to, allowing pharmacy to pharmacy donation of unexpired prescription drug stock.[ 2020 c 264 § 2.]
WA Rev Code § 69.70.900 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.70 - Access to Prescription Drugs.|69.70.900 - Effective date.

RCW 69.70.900 Effective date.This act takes effect July 1, 2014.[ 2013 c 260 § 12.]
WA Rev Code § 69.75.010 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.010 - Definitions.

RCW 69.75.010 Definitions.The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.(1) "Common carrier" means any person who holds himself or herself out to the general public as a provider for hire of the transportation by water, land, or air of merchandise, whether or not the person actually operates the vessel, vehicle, or aircraft by which the transportation is provided, between a port or place and a port or place in the United States.(2) "Finished drug product" means a drug legally marketed under the federal food, drug, and cosmetic act, 21 U.S.C. 321 et seq., that is in finished dosage form.(3) "Proof of age" means any document issued by a governmental agency that contains a description or photograph of the person and gives the person's date of birth, including a passport, military identification card, or driver's license.(4) "Unfinished dextromethorphan" means dextromethorphan in any form, compound, mixture, or preparation that is not a drug in finished dosage form.[ 2014 c 64 § 1.]
WA Rev Code § 69.75.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.020 - Retail sales—Proof of age from purchaser—Unlawful acts, exceptions—Penalties.

RCW 69.75.020 Retail sales—Proof of age from purchaser—Unlawful acts, exceptions—Penalties.(1) A person making a retail sale of a finished drug product containing any quantity of dextromethorphan must require and obtain proof of age from the purchaser before completing the sale, unless from the purchaser's outward appearance the person making the sale would reasonably presume the purchaser to be twenty-five years of age or older.(2) It is unlawful for any:(a) Commercial entity to knowingly or willfully sell or trade a finished drug product containing any quantity of dextromethorphan to a person less than eighteen years of age; or(b) Person who is less than eighteen years of age to purchase a finished drug product containing any quantity of dextromethorphan.(3) Subsection (2)(a) and (b) of this section do [does] not apply if an individual under eighteen years of age:(a) Supplies proof at the time of sale that such individual is actively enrolled in the military and presents a valid military identification card; or(b) Supplies proof of emancipation.(4)(a) Any manufacturer, distributor, or retailer whose employee or representative, during the course of the employee's or representative's employment or association with that manufacturer, distributor, or retailer sells or trades dextromethorphan in violation of subsection (2)(a) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the manufacturer, distributor, or retailer is guilty of a class 1 civil infraction as provided in RCW 7.80.120, except for any manufacturer, distributor, or retailer who demonstrates a good faith effort to comply with the requirements of this chapter.(b) Any employee or representative of a manufacturer, distributor, or retailer who, during the course of the employee's or representative's employment or association with that manufacturer, distributor, or retailer sells or trades dextromethorphan in violation of subsection (2)(a) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the employee or representative is guilty of a class 1 civil infraction as provided in RCW 7.80.120.(c) Any person who purchases dextromethorphan in violation of subsection (2)(b) of this section must be given a written warning by a law enforcement agency for the first offense. For any subsequent offense, the person is guilty of a class 1 civil infraction as provided in RCW 7.80.120.[ 2014 c 64 § 2.]
WA Rev Code § 69.75.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.030 - List of products containing dextromethorphan, trade association representing manufacturers to supply.

RCW 69.75.030 List of products containing dextromethorphan, trade association representing manufacturers to supply.The trade association representing manufacturers of dextromethorphan shall supply to the pharmacy quality assurance commission and requesting licensed retailers an initial list of products containing dextromethorphan that its members market. This list shall be updated on an annual basis. The trade association representing manufacturers of dextromethorphan shall make other reasonable efforts to communicate the requirements of chapter 64, Laws of 2014.[ 2014 c 64 § 3.]
WA Rev Code § 69.75.040 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.040 - Construction of chapter.

RCW 69.75.040 Construction of chapter.(1) Nothing in this chapter is construed to impose any compliance requirement on a retail entity other than manually obtaining and verifying proof of age as a condition of sale, including placement of products in a specific place within a store, other restrictions on consumers' direct access to finished drug products, or the maintenance of transaction records.(2) The provisions of this chapter do not apply to medication containing dextromethorphan that is sold pursuant to a valid prescription.[ 2014 c 64 § 4.]
WA Rev Code § 69.75.050 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.050 - Preemption.

RCW 69.75.050 Preemption.This chapter preempts any ordinance regulating the sale, distribution, receipt, or possession of dextromethorphan enacted by a county, city, town, or other political subdivision of this state, and dextromethorphan is not subject to further regulation by such subdivisions.[ 2014 c 64 § 5.]
WA Rev Code § 69.75.900 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.75 - Dextromethorphan.|69.75.900 - Effective date—2014 c 64.

RCW 69.75.900 Effective date—2014 c 64.This act takes effect July 1, 2015.[ 2014 c 64 § 7.]
WA Rev Code § 69.77.010 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.010 - Findings—Intent.

RCW 69.77.010 Findings—Intent.The legislature finds that the process for approval of investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments over time, but the process often takes many years. Patients who have a terminal illness do not have the luxury of waiting until an investigational drug, biological product, or device receives final approval from the United States food and drug administration. The legislature further finds that patients who have a terminal illness should be permitted to pursue the preservation of their own lives by accessing available investigational drugs, biological products, and devices. The use of available investigational drugs, biological products, and devices is a decision that should be made by the patient with a terminal illness in consultation with the patient's health care provider so that the decision to use an investigational drug, biological product, or device is made with full awareness of the potential risks, benefits, and consequences to the patient and the patient's family.The legislature, therefore, intends to allow terminally ill patients to use potentially lifesaving investigational drugs, biological products, and devices.[ 2017 c 212 § 1.]
WA Rev Code § 69.77.020 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.020 - Definitions.

RCW 69.77.020 Definitions.The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.(1) "Eligible patient" means an individual who meets the requirements of RCW 69.77.040.(2) "Health care facility" means a clinic, nursing home, laboratory, office, or similar place where a health care provider provides health care to patients.(3) "Hospital" means a health care institution licensed under chapter 70.41, 71.12, or 72.23 RCW.(4) "Investigational product" means a drug, biological product, or device that has successfully completed phase one and is currently in a subsequent phase of a clinical trial approved by the United States food and drug administration assessing the safety of the drug, biological product, or device under section 505 of the federal food, drug, and cosmetic act, 21 U.S.C. Sec. 355.(5) "Issuer" means any state purchased health care programs under chapter 41.05 or 74.09 RCW, a disability insurer regulated under chapter 48.20 or 48.21 RCW, a health care service contractor as defined in RCW 48.44.010, or a health maintenance organization as defined in RCW 48.46.020.(6) "Manufacturer" means a person or other entity engaged in the manufacture or distribution of drugs, biological products, or devices.(7) "Physician" means a physician licensed under chapter 18.71 RCW or an osteopathic physician and surgeon licensed under chapter 18.57 RCW.(8) "Serious or immediately life-threatening disease or condition" means a stage of disease in which there is reasonable likelihood that death will occur within six months or in which premature death is likely without early treatment.[ 2017 c 212 § 2.]
WA Rev Code § 69.77.030 (2021)
2021 Revised Code of Washington|Title 69 - Food, Drugs, Cosmetics, and Poisons|Chapter 69.77 - Investigational Drugs, Biological Products, and Devices.|69.77.030 - Eligible patient and treating physician may request investigational product—Manufacturer may make for treatment—Agreement.

RCW 69.77.030 Eligible patient and treating physician may request investigational product—Manufacturer may make for treatment—Agreement.(1) An eligible patient and his or her treating physician may request that a manufacturer make an investigational product available for treatment of the patient. The request must include a copy of the written informed consent form described in RCW 69.77.050 and an explanation of why the treating physician believes the investigational product may help the patient.(2) Upon receipt of the request and the written informed consent form, the manufacturer may, but is not required to, make the investigational product available for treatment of the eligible patient. Prior to making the investigational product available, the manufacturer shall enter into an agreement with the treating physician and the eligible patient providing that the manufacturer will transfer the investigational product to the physician and the physician will use the investigational product to treat the eligible patient.[ 2017 c 212 § 3.]